C17H20F2N4O3S
Neat
398.43
OMARIGLIPTIN; 1226781-44-7; MK-3102; Omarigliptina; Omarigliptine; CVP59Q4JE1; DTXSID70153678; (2R, 3S, 5R)-2-(2, 5-difluorophenyl)-5-(2-methylsulfonyl-4, 6-dihydropyrrolo[3, 4-c]pyrazol-5-yl)oxan-3-amine; 2H-Pyran-3-amine, 2-(2, 5-difluorophenyl)-5-(2, 6-dihydro-2-(methylsulfonyl)pyrrolo(3, 4-c)pyrazol-5(4H)-yl)tetrahydro-, (2R, 3S, 5R)-; omarigliptinum; (2R, 3S, 5R)-2-(2, 5-difluorophenyl)-5-(2-methylsulfonyl-4, 6-dihydropyrrolo(3, 4-c)pyrazol-5-yl)oxan-3-amine; RefChem:856762; DTXCID1076169; (2R, 3S, 5R)-2-(2, 5-difluorophenyl)-5-(2-methanesulfonyl-2H, 4H, 5H, 6H-pyrrolo(3, 4-c)pyrazol-5-yl)oxan-3-amine; MFCD22573261; (2R, 3S, 5R)-2-(2, 5-DIFLUOROPHENYL)-5-(2-(METHYLSULFONYL)PYRROLO[3, 4-C]PYRAZOL-5(2H, 4H, 6H)-YL)TETRAHYDRO-2H-PYRAN-3-AMINE; (2R, 3S, 5R)-2-(2, 5-difluorophenyl)-5-(2-(methylsulfonyl)-2, 6-dihydropyrrolo[3, 4-c]pyrazol-5(4H)-yl)tetrahydro-2H-pyran-3-amine; Omarigliptin (MK-3102); 2H-Pyran-3-amine, 2-(2, 5-difluorophenyl)-5-[2, 6-dihydro-2-(methylsulfonyl)pyrrolo[3, 4-c]pyrazol-5(4H)-yl]tetrahydro-, (2R, 3S and 5R)-; UNII-CVP59Q4JE1
(2R, 3S, 5R)-2-(2, 5-difluorophenyl)-5-(2-methylsulfonyl-4, 6-dihydropyrrolo[3 and 4-c]pyrazol-5-yl)oxan-3-amine
InChI=1S/C17H20F2N4O3S/c1-27(24,25)23-7-10-6-22(8-16(10)21-23)12-5-15(20)17(26-9-12)13-4-11(18)2-3-14(13)19/h2-4,7,12,15,17H,5-6,8-9,20H2,1H3/t12-,15+,17-/m1/s1